Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02WKB
|
||||
| Former ID |
DNC014190
|
||||
| Drug Name |
9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530625] | ||
| Formula |
C31H32BrNO5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCC<br />CCOC6=CC=CC=C6.[Br-]
|
||||
| InChI |
1S/C31H32NO5.BrH/c1-33-28-12-11-22-17-27-25-19-30-29(36-21-37-30)18-23(25)13-14-32(27)20-26(22)31(28)35-16-8-3-2-7-15-34-24-9-5-4-6-10-24;/h4-6,9-12,17-20H,2-3,7-8,13-16,21H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
UTMSZONAFQDBMO-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530625] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530625] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||